Kevin B. Kimberlin

This is a page dedicated to get more information for investors to evaluate the management style of Kevin B. Kimberlin who is a Co-founder of Immune Response Corp.

Here on this page we are inviting all readers to discuss Kevin B. Kimberlin. You may anonymously post comments with any information that they have about Kevin B. Kimberlin. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

Kevin Kimberlin, a member of our Board of Directors, beneficially owns approximately 43.7% of our outstanding common stock and has the rights to acquire approximately 484,464,000 additional shares of our common stock, which could result in ownership of up to approximately 86.3% of our outstanding shares and could allow him to control or influence stockholder votes.